Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6867006

Title:Antibodies to human chemotactic protein
Inventors:Li, Haodong; Gaithersburg, MD, USA
Ruben, Steven M.; Olney, MD, USA
Sutton, III, Granger; Columbia, MD, USA
Summary:Described herein is a new polynucleotide encoding a human chemotactic polypeptide, the associated DNA and RNA, and a procedure for producing such a polypeptide by recombinant techniques. Further disclosed are polypeptide antagonists and diagnostic assays for identifying mutations in nucleic acid sequences encoding such a polypeptide, and for detecting altered levels of the polypeptide in the screening and detection of diseases. Applications are included in stem cell mobilization, myeloprotection, neuronal protection, wound healing, in the treatment of cancer and parasitic infections, and in the regulation of hematopoiesis.
Abstract:A human chemotactic polypeptide, DNA (RNA) encoding it, and a procedure for producing such a polypeptide by recombinant techniques are disclosed. Also disclosed are methods of using the polypeptide for a number of purposes, including: stem cell mobilization, myeloprotection, neuronal protection, treating tumors, wound healing, treating parasitic infection, and regulating hematopoiesis. Also disclosed are polypeptide antagonists and diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases are also disclosed.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6867006
Application Number:US2002000141965
Date Filed:10/05/2002
Date Published:15/03/2005
Assignee:Human Genome Sciences, Inc., Rockville, MD, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021